Key statistics
On Friday, OptimizeRx Corp (OPRX:NAQ) closed at 7.88, 13.87% above the 52 week low of 6.92 set on Oct 09, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 7.50 |
---|---|
High | 7.99 |
Low | 7.50 |
Bid | 7.50 |
Offer | 12.50 |
Previous close | 7.86 |
Average volume | 108.61k |
---|---|
Shares outstanding | 18.32m |
Free float | 15.87m |
P/E (TTM) | -- |
Market cap | 144.38m USD |
EPS (TTM) | -1.00 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value
- OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences
- OptimizeRx Reports Second Quarter 2024 Financial Results
- OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET
- OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation
- OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients
- New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations
- OptimizeRx Reports First Quarter 2024 Financial Results
- OptimizeRx to Participate in Upcoming Investor Conferences
- OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET
More ▼